{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:14:42Z","timestamp":1790813682289,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013285","name":"EC | European Commission - Executive Agency for SMEs | Competitiveness of Enterprises and Small and Medium-sized Enterprises","doi-asserted-by":"publisher","award":["305507"],"award-info":[{"award-number":["305507"]}],"id":[{"id":"10.13039\/100013285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clusterin (CLU) is induced in many organs after tissue injury or remodeling. Recently, we show that CLU levels are increased in plasma and left ventricle (LV) after MI, however, the mechanisms involved are not yet elucidated. On the other hand, it has been shown that the activity of the protein degradation systems (PDS) is affected after MI with a decrease in ubiquitin proteasome system (UPS) and an increase in macroautophagy. The aim of this study was to decipher if the increased CLU levels after MI are in part due to the alteration of PDS activity. Rat neonate cardiomyocytes (NCM) were treated with different modulators of UPS and macroautophagy in order to decipher their role in CLU expression, secretion, and degradation. We observed that inhibition of UPS activity in NCM increased CLU mRNA levels, its intracellular protein levels (p-CLU and m-CLU) and its secreted form (s-CLU). Macroautophagy was also induced after MG132 treatment but is not active. The inhibition of macroautophagy induction in MG132-treated NCM increased CLU mRNA and m-CLU levels, but not s-CLU compared to NCM only treated by MG132. We also demonstrate that CLU can be degraded in NCM through proteasome and lysosome by a macroautophagy independent pathway. In another hand, CLU silencing in NCM has no effect either on macroautophagy or apoptosis induced by MG132. However, the overexpression of CLU secreted isoform in H9c2 cells, but not in NCM decreased apoptosis after MG132 treatment. Finally, we observed that increased CLU levels in hypertrophied NCM and in failing human hearts are associated with proteasome inhibition and macroautophagy alteration. All these data suggest that increased CLU expression and secretion after MI is, in part, due to a defect of UPS and macroautophagy activities in the heart and may have a protective effect by decreasing apoptosis induced by proteasome inhibition.<\/jats:p>","DOI":"10.1038\/s41419-019-1857-x","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T23:03:30Z","timestamp":1565651010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity"],"prefix":"10.1038","volume":"10","author":[{"given":"Annie","family":"Turkieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Porouchani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Beseme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggy","family":"Chwastyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Balligand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-1487","authenticated-orcid":false,"given":"Florence","family":"Pinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"1857_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/bmc-2015-0026","volume":"7","author":"P Rohne","year":"2016","unstructured":"Rohne, P., Prochnow, H. & Koch-Brandt, C. The CLU-files: disentanglement of a mystery. Biomol. Concepts 7, 1\u201315 (2016).","journal-title":"Biomol. Concepts"},{"key":"1857_CR2","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.biocel.2012.09.012","volume":"44","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis. Int. J. Biochem. Cell. Biol. 44, 2308\u20132320 (2012).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"1857_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijcard.2015.06.008","volume":"197","author":"E Foglio","year":"2015","unstructured":"Foglio, E. et al. Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis. Int. J. Cardiol. 197, 333\u2013347 (2015).","journal-title":"Int. J. Cardiol."},{"key":"1857_CR4","first-page":"177","volume":"80","author":"A V\u00e4kev\u00e4","year":"1993","unstructured":"V\u00e4kev\u00e4, A., Laurila, P. & Meri, S. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Immunology 80, 177\u2013182 (1993).","journal-title":"Immunology"},{"key":"1857_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0531-5565(02)00139-0","volume":"37","author":"IP Trougakos","year":"2002","unstructured":"Trougakos, I. P. et al. Serum levels of the senescence biomarker clusterin\/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp. Gerontol. 37, 1175\u20131187 (2002).","journal-title":"Exp. Gerontol."},{"key":"1857_CR6","doi-asserted-by":"publisher","first-page":"e004838","DOI":"10.1161\/CIRCHEARTFAILURE.117.004838","volume":"11","author":"A Turkieh","year":"2018","unstructured":"Turkieh, A. et al. Expression and implication of clusterin in left ventricular remodeling after myocardial infarction. Circ. Heart Fail. 11, e004838\u2013e004850 (2018).","journal-title":"Circ. Heart Fail."},{"key":"1857_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/cvr\/cvp309","volume":"85","author":"X Yu","year":"2010","unstructured":"Yu, X. & Kem, D. C. Proteasome inhibition during myocardial infarction. Cardiovasc. Res. 85, 312\u2013320 (2010).","journal-title":"Cardiovasc. Res."},{"key":"1857_CR8","doi-asserted-by":"publisher","first-page":"H337","DOI":"10.1152\/ajpheart.00604.2012","volume":"304","author":"J Calise","year":"2013","unstructured":"Calise, J. & Powell, S. R. The ubiquitin proteasome system and myocardial ischemia. Am. J. Physiol. Circ. Physiol. 304, H337\u2013H349 (2013).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"1857_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cvr\/cvr073","volume":"91","author":"H Kanamori","year":"2011","unstructured":"Kanamori, H. et al. The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc. Res. 91, 330\u2013339 (2011).","journal-title":"Cardiovasc. Res."},{"key":"1857_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2008.03.025","volume":"45","author":"X Wang","year":"2008","unstructured":"Wang, X., Su, H. & Ranek, M. J. Protein quality control and degradation in cardiomyocytes. J. Mol. Cell. Cardiol. 45, 11\u201327 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1857_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature05853","volume":"447","author":"UB Pandey","year":"2007","unstructured":"Pandey, U. B. et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859\u2013863 (2007).","journal-title":"Nature"},{"key":"1857_CR12","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.107.763870","volume":"117","author":"P Tannous","year":"2008","unstructured":"Tannous, P. et al. Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 117, 3070\u20133078 (2008).","journal-title":"Circulation"},{"key":"1857_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/onc.2009.343","volume":"29","author":"K Zhu","year":"2010","unstructured":"Zhu, K., Dunner, K. & McConkey, D. J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29, 451\u2013462 (2010).","journal-title":"Oncogene"},{"key":"1857_CR14","first-page":"214","volume":"1","author":"Q Zheng","year":"2011","unstructured":"Zheng, Q., Su, H., Tian, Z. & Wang, X. Proteasome malfunction activates macroautophagy in the heart. Am. J. Cardiovasc. Dis. 1, 214\u2013226 (2011).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"1857_CR15","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.4161\/auto.25573","volume":"9","author":"XJ Wang","year":"2013","unstructured":"Wang, X. J. et al. A novel crosstalk between two major protein degradation systems. Autophagy 9, 1500\u20131508 (2013).","journal-title":"Autophagy"},{"key":"1857_CR16","first-page":"1","volume":"9","author":"Z Tian","year":"2014","unstructured":"Tian, Z. et al. Autophagic-lysosomal inhibition compromises ubiquitin-proteasome system performance in a p62 dependent manner in cardiomyocytes. PLoS ONE 9, 1\u201310 (2014).","journal-title":"PLoS ONE"},{"key":"1857_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbadis.2014.07.028","volume":"1852","author":"C Wang","year":"2015","unstructured":"Wang, C. & Wang, X. The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity. Biochim. Biophys. Acta Mol. Basis Dis. 1852, 188\u2013194 (2015).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1857_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","volume":"71","author":"X Wang","year":"2014","unstructured":"Wang, X. & Robbins, J. Proteasomal and lysosomal protein degradation and heart disease. J. Mol. Cell. Cardiol. 71, 16\u201324 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1857_CR19","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1172\/JCI45709","volume":"121","author":"J Li","year":"2011","unstructured":"Li, J. et al. Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia\/reperfusion injury in mice. J. Clin. Invest. 121, 3689\u20133700 (2011).","journal-title":"J. Clin. Invest."},{"key":"1857_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCRESAHA.112.270983","volume":"111","author":"Z Tian","year":"2012","unstructured":"Tian, Z. et al. Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ. Res. 111, 532\u2013542 (2012).","journal-title":"Circ. Res."},{"key":"1857_CR21","doi-asserted-by":"publisher","first-page":"H1283","DOI":"10.1152\/ajpheart.00249.2012","volume":"304","author":"SM Day","year":"2013","unstructured":"Day, S. M. The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am. J. Physiol. Heart Circ. Physiol. 304, H1283\u2013H1293 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1857_CR22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.4161\/auto.21036","volume":"8","author":"X Ma","year":"2012","unstructured":"Ma, X. et al. Autophagy is impaired in cardiac ischemia-reperfusion injury. Autophagy 8, 1394\u20131396 (2012).","journal-title":"Autophagy"},{"key":"1857_CR23","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","volume":"54","author":"SJ Buss","year":"2009","unstructured":"Buss, S. J. et al. Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J. Am. Coll. Cardiol. 54, 2435\u20132446 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1857_CR24","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.jacc.2018.02.066","volume":"71","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta, S. et al. Trehalose-induced activation of autophagy improves cardiac remodeling after myocardial infarction. J. Am. Coll. Cardiol. 71, 1999\u20132010 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1857_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.freeradbiomed.2009.01.025","volume":"46","author":"E Balantinou","year":"2009","unstructured":"Balantinou, E., Trougakos, I. P., Chondrogianni, N., Margaritis, L. H. & Gonos, E. S. Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways. Free Radic. Biol. Med. 46, 1267\u20131274 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"1857_CR26","first-page":"1","volume":"5","author":"F Zhang","year":"2014","unstructured":"Zhang, F. et al. Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival. Nat. Commun. 5, 1\u201313 (2014).","journal-title":"Nat. Commun."},{"key":"1857_CR27","doi-asserted-by":"publisher","first-page":"F160","DOI":"10.1152\/ajprenal.00304.2015","volume":"310","author":"HA Alnasser","year":"2016","unstructured":"Alnasser, H. A. et al. Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells. Am. J. Physiol. Ren. Physiol. 310, F160\u2013F173 (2016).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1857_CR28","doi-asserted-by":"publisher","first-page":"H2193","DOI":"10.1152\/ajpheart.00355.2005","volume":"289","author":"PAJ Krijnen","year":"2005","unstructured":"Krijnen, P. A. J. et al. Clusterin: a protective mediator for ischemic cardiomyocytes? Am. J. Physiol. Circ. Physiol. 289, H2193\u2013H2202 (2005).","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"1857_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3858\/emm.2011.43.1.006","volume":"43","author":"HO Jun","year":"2011","unstructured":"Jun, H. O. et al. Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt\/GSK-3\u03b2 signaling pathway. Exp. Mol. Med. 43, 53\u201361 (2011).","journal-title":"Exp. Mol. Med."},{"key":"1857_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1756-9966-31-73","volume":"31","author":"Y Tang","year":"2012","unstructured":"Tang, Y., Liu, F., Zheng, C., Sun, S. & Jiang, Y. Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1\/2 inactivation. J. Exp. Clin. Cancer Res. 31, 73\u201382 (2012).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1857_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jcp.21671","volume":"219","author":"F Rizzi","year":"2009","unstructured":"Rizzi, F., Caccamo, A. E., Belloni, L. & Bettuzzi, S. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells. J. Cell. Physiol. 219, 314\u2013323 (2009).","journal-title":"J. Cell. Physiol."},{"key":"1857_CR32","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1021\/bi952981b","volume":"35","author":"KB Reddy","year":"1996","unstructured":"Reddy, K. B., Jin, G., Karode, M. C., Harmony, J. A. K. & Howe, P. H. Transforming growth factor \u03b2 (TGF\u03b2)-induced nuclear localization of apolipoprotein J\/clusterin in epithelial cells. Biochemistry 35, 6157\u20136163 (1996).","journal-title":"Biochemistry"},{"key":"1857_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5115\/acb.2011.44.3.169","volume":"44","author":"N Kim","year":"2011","unstructured":"Kim, N. & Choi, W. S. Proapoptotic role of nuclear clusterin in brain. Anat. Cell. Biol. 44, 169\u2013175 (2011).","journal-title":"Anat. Cell. Biol."},{"key":"1857_CR34","first-page":"1","volume":"4","author":"F Cacciapuoti","year":"2014","unstructured":"Cacciapuoti, F. Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH). Am. J. Cardiovasc. Dis. 4, 1\u20135 (2014).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"1857_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.003","volume":"95","author":"K Nishida","year":"2016","unstructured":"Nishida, K. & Otsu, K. Autophagy during cardiac remodeling. J. Mol. Cell. Cardiol. 95, 11\u201318 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1857_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BJ20051190","volume":"395","author":"F Loison","year":"2006","unstructured":"Loison, F. et al. Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1\u2013HSF2 heterocomplexes. Biochem. J. 395, 223\u2013231 (2006).","journal-title":"Biochem. J."},{"key":"1857_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/bj3280045","volume":"328","author":"D Michel","year":"1997","unstructured":"Michel, D., Chatelain, G., North, S. & Brun, G. Stress-induced transcription of the clusterin\/apoJ gene. Biochem. J. 328, 45\u201350 (1997).","journal-title":"Biochem. J."},{"key":"1857_CR38","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1007\/s00018-011-0684-8","volume":"68","author":"AR Wyatt","year":"2011","unstructured":"Wyatt, A. R. et al. Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell. Mol. Life Sci. 68, 3919\u20133931 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"1857_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-019-0662-1","volume":"7","author":"Y Endo","year":"2019","unstructured":"Endo, Y. et al. Apolipoprotein E and clusterin inhibit the early phase of amyloid- \u03b2 aggregation in an in vitro model of cerebral amyloid angiopathy. Acta Neuropathol. Commun. 7, 12\u201322 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"1857_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1750-3639.2005.tb00504.x","volume":"15","author":"I Ferrer","year":"2005","unstructured":"Ferrer, I. et al. Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis. Brain Pathol. 15, 101\u2013108 (2005).","journal-title":"Brain Pathol."},{"key":"1857_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-017-0481-1","volume":"5","author":"JM Gregory","year":"2017","unstructured":"Gregory, J. M. et al. Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol. Commun. 5, 81\u201396 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"1857_CR42","doi-asserted-by":"publisher","first-page":"18644","DOI":"10.1074\/jbc.272.30.18644","volume":"272","author":"SM Hammad","year":"1997","unstructured":"Hammad, S. M., Ranganathan, S., Loukinova, E., Twal, W. O. & Argraves, W. S. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2\/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J. Biol. Chem. 272, 18644\u201318649 (1997).","journal-title":"J. Biol. Chem."},{"key":"1857_CR43","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M209233200","volume":"278","author":"KS Leskov","year":"2003","unstructured":"Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. & Boothman, D. A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590\u201311600 (2003).","journal-title":"J. Biol. Chem."},{"key":"1857_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11596-015-1381-x","volume":"35","author":"LQ Wang","year":"2015","unstructured":"Wang, L. Q., Cheng, X. S., Huang, C. H., Huang, B. & Liang, Q. Rapamycin protects cardiomyocytes against anoxia\/reoxygenation injury by inducing autophagy through the PI3k\/Akt pathway. J. Huazhong Univ. Sci. Technol. Med. Sci. 35, 10\u201315 (2015).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"1857_CR45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1074\/jbc.M109.070037","volume":"285","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi, S. et al. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J. Biol. Chem. 285, 793\u2013804 (2010).","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1857-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:28:11Z","timestamp":1671211691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1857-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1857-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"608"}}